Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in

Humans Clarithromycin / pharmacology Levofloxacin / pharmacology Helicobacter pylori Helicobacter Infections / drug therapy RNA, Ribosomal, 23S / genetics Molecular Docking Simulation Croatia Drug Resistance, Bacterial / genetics Microbial Sensitivity Tests Anti-Bacterial Agents / pharmacology Biopsy
23S rRNA antibiotic resistance gyrA gyrB molecular docking point mutations

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Sep 2023
Historique:
received: 31 08 2023
revised: 17 09 2023
accepted: 20 09 2023
medline: 1 11 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

Point mutations in the

Identifiants

DOI: 10.3390/ijms241914560 PMID: 37834008 PMC: PMC10572715
pubmed: 37834008
pii: ijms241914560
doi: 10.3390/ijms241914560
pmc: PMC10572715
pii:
doi:

Substances chimiques

Clarithromycin H1250JIK0A
Levofloxacin 6GNT3Y5LMF
RNA, Ribosomal, 23S 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Biol Chem. 1983 Oct 25;258(20):12702-6
pubmed: 6195156
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0218821
pubmed: 35652644
Emerg Microbes Infect. 2022 Dec;11(1):293-305
pubmed: 34935599
J Clin Med. 2019 Nov 17;8(11):
pubmed: 31744181
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S7-10
pubmed: 20586870
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629
pubmed: 34002081
Indian J Med Microbiol. 2018 Apr-Jun;36(2):265-272
pubmed: 30084422
J Korean Med Sci. 2002 Oct;17(5):599-603
pubmed: 12378008
Methods Mol Biol. 2013;943:279-87
pubmed: 23104297
Microb Genom. 2020 Mar;6(3):
pubmed: 32118532
Cell. 2012 Oct 26;151(3):508-20
pubmed: 23101624
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Gastroenterology. 2018 Nov;155(5):1372-1382.e17
pubmed: 29990487
PLoS Comput Biol. 2022 Jun 2;18(6):e1009783
pubmed: 35653385
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Clin Microbiol. 2020 Feb 24;58(3):
pubmed: 31801839
Gut. 2021 Oct;70(10):1815-1822
pubmed: 33837118
Am J Gastroenterol. 2017 Feb;112(2):212-239
pubmed: 28071659
Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380
pubmed: 36305812
BMC Microbiol. 2021 Feb 3;21(1):38
pubmed: 33535966
FASEB J. 2020 Jan;34(1):610-618
pubmed: 31914672
Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):317-321
pubmed: 28889650
World J Gastroenterol. 2016 Sep 7;22(33):7587-94
pubmed: 27672279
Int J Antimicrob Agents. 2015 Mar;45(3):244-8
pubmed: 25499186
J Pers Med. 2021 Jun 09;11(6):
pubmed: 34207870
J Glob Antimicrob Resist. 2017 Jun;9:43-46
pubmed: 28343971
J Med Microbiol. 2017 May;66(5):551-559
pubmed: 28504927
Front Cell Infect Microbiol. 2021 Feb 11;10:539115
pubmed: 33643927
Diseases. 2021 Sep 23;9(4):
pubmed: 34698140
Microorganisms. 2020 Jun 11;8(6):
pubmed: 32545318
Gastroenterol Res Pract. 2013;2013:259457
pubmed: 23710166
Antimicrob Agents Chemother. 2012 Jan;56(1):550-1
pubmed: 22064536
Front Mol Biosci. 2021 Jul 28;8:729513
pubmed: 34395534
PeerJ. 2021 Jun 09;9:e11518
pubmed: 34178444
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):495-500
pubmed: 23752823
Microb Drug Resist. 2017 Apr;23(3):351-358
pubmed: 27391421
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Am J Trop Med Hyg. 2018 Apr;98(4):1051-1055
pubmed: 29405113
J Antimicrob Chemother. 1997 Aug;40(2):283-6
pubmed: 9301997
Antimicrob Agents Chemother. 1995 Jan;39(1):107-11
pubmed: 7695290
Infect Drug Resist. 2020 Jul 06;13:2145-2153
pubmed: 32753910
Antibiotics (Basel). 2020 Oct 21;9(10):
pubmed: 33096925
Infect Drug Resist. 2020 Jan 30;13:311-322
pubmed: 32099422
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):42-52
pubmed: 29154808
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Aliment Pharmacol Ther. 2016 Feb;43(4):514-33
pubmed: 26694080
Can J Gastroenterol Hepatol. 2019 Jul 1;2019:8481375
pubmed: 31355162
Front Microbiol. 2018 Dec 18;9:3154
pubmed: 30619218
Antimicrob Agents Chemother. 2004 Sep;48(9):3567-9
pubmed: 15328128
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
J Med Microbiol. 2007 Sep;56(Pt 9):1174-1180
pubmed: 17761479
Helicobacter. 2021 Apr;26(2):e12782
pubmed: 33491828
Prim Care. 2018 Sep;45(3):467-484
pubmed: 30115335
Helicobacter. 2006 Aug;11(4):243-9
pubmed: 16882327
J Clin Med. 2019 Jan 07;8(1):
pubmed: 30621024
Antimicrob Resist Infect Control. 2019 Feb 15;8:40
pubmed: 30815255
Antimicrob Agents Chemother. 1996 Feb;40(2):477-80
pubmed: 8834903
J Mol Biol. 2017 Feb 3;429(3):365-371
pubmed: 27964945
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
Cells. 2020 Dec 25;10(1):
pubmed: 33375694
Gut. 2015 Sep;64(9):1353-67
pubmed: 26187502
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80
pubmed: 11860399

Auteurs

Ivica Šamanić (I)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
ORCID: 0000-0001-8807-8184

Blanka Dadić (B)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.

Željka Sanader Maršić (Ž)

Department of Physics, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
ORCID: 0000-0003-3660-145X

Mia Dželalija (M)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
ORCID: 0000-0002-7284-9519

Ana Maravić (A)

Department of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.

Hrvoje Kalinić (H)

Department of Compute Science, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.

Pavle Vrebalov Cindro (P)

Department of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.

Željko Šundov (Ž)

Department of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia.

Marija Tonkić (M)

Department of Medical Microbiology and Parasitology, School of Medicine, University of Split, 21000 Split, Croatia.

Ante Tonkić (A)

Department of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia.

Jonatan Vuković (J)

Department of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Department of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Molecular Characterization and Mutational...
questionsmedicales.fr › Composés chimiques organiques › Lactones › Érythromycine › Clarithromycine › Molecular Characterization and Mutational...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Quinolinone › Fluoroquinolones › Ofloxacine › Lévofloxacine › Molecular Characterization and Mutational...
questionsmedicales.fr › Bactéries › Proteobacteria › Epsilonproteobacteria › Campylobacterales › Helicobacteraceae › Helicobacter › Helicobacter pylori › Molecular Characterization and Mutational...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Helicobacter › Molecular Characterization and Mutational...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 23S › Molecular Characterization and Mutational...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de docking moléculaire › Molecular Characterization and Mutational...
questionsmedicales.fr › Régions géographiques › Europe › Europe de l'Est › Croatie › Molecular Characterization and Mutational...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Molecular Characterization and Mutational...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Molecular Characterization and Mutational...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Molecular Characterization and Mutational...
questionsmedicales.fr › Techniques d'investigation › Techniques cytologiques › Cytodiagnostic › Biopsie › Molecular Characterization and Mutational...